Line 9: |
Line 9: |
| | | |
| =Introduction= | | =Introduction= |
− | | + | Poxviruses are among the most easily recognized of all viruses, owing to the lesion by which they have gained their name. Once inside cell, proliferation then lysis, giving way to a characteristic pock with a necrotic center. Poxviruses have risen to fame both for their ability to be eradicated (small pox) as well as their use in fighting other viruses (canarypox vaccines). |
| | | |
| =Morphology= | | =Morphology= |
Line 16: |
Line 16: |
| *Non-structural proteins: | | *Non-structural proteins: |
| **Viral epidermal growth factor, which stimulates cell growth causing the raised edge of pustule | | **Viral epidermal growth factor, which stimulates cell growth causing the raised edge of pustule |
− | **Viral tumor necrosis factor, which is non-functioning and acts as an anti-inflammatory by competing with TNF-<alpha> | + | **Viral tumor necrosis factor, which is non-functioning and acts as an anti-inflammatory by competing with TNF-alpha |
| + | **Viral IL-10, which reduces the Th-1 cell mediated response |
| + | |
| + | =Therapeutic Use= |
| + | Recombinant Vaccines |
| + | *Poxviruses can be used as heat-stable vectors for vaccines against other viruses |
| + | *Grown in host cell lines or on the surface of chick chorioallantoic membranes in ovo (primordial ectoderm) |
| + | *This was first accomplished by the recombination of cowpox and variola (smallpox) in the creation of the smallpox vaccine (vaccinia) |
| + | *More recently, the French used this technique in the creation of the oral rabies vaccine used among the wild fox population: |
| + | **Recombinant virus inserts a plasmid encoding rabies gene in place of thymidine kinase gene |
| + | *Canarypox vaccines now exist for [[Feline Leukemia Virus (FeLV)|FeLV]] and [[Rabies]] |
| + | **Undergoes a single cycle of replication without producing infectious virus in mammals |
| | | |
| =Virulence and Pathogenesis= | | =Virulence and Pathogenesis= |
− | *Once inside cell, proliferation then lysis, giving way to a characteristic pock with a necrotic center | + | *Primary replication in abraded squamous epithelium |
| + | *Viremia followed by multiple epidermal infections |
| + | *Ballooning then necrosis (hydropic degeneration) of epidermal cells |
| + | *Concurrent proliferation or adjacent epidermis (GF driven), creating more cells for the virus to infect |
| + | *All three result in classical sequence of lesions: |
| + | **Papule (proliferation) |
| + | **Vesicle (fluid filled) |
| + | **Pustule (lesion breaks) |
| + | **Scab formation (healing begins) |
| + | *Pock center can succumb to secondary infection |
| + | *Resolution in 3-4 weeks |
| + | *Some poxviruses can spread to the upper respiratory tract or viscera, causing more serious pathology |
| | | |
| =Epidemiology= | | =Epidemiology= |
| *Spread quickly in unhygienic circumstances | | *Spread quickly in unhygienic circumstances |
| *Can survive for years in dust | | *Can survive for years in dust |
| + | |
| + | =Diagnosis= |
| + | *Clinical signs |
| + | *Histology |
| + | *Electron microscopy |
| + | *PCR, IIF |
| | | |
| =Types and Subtypes= | | =Types and Subtypes= |
Line 32: |
Line 60: |
| *[[Cow pox]], which also causes cat pox | | *[[Cow pox]], which also causes cat pox |
| *Small pox (variola) | | *Small pox (variola) |
− | *Orf | + | *[[Orf]] |
| *Seal pox | | *Seal pox |
| *Pig pox | | *Pig pox |
− | *Sheep pox (exotic to EU) | + | *Sheep/Goat pox (exotic to EU) |
− | *Goat pox (exotic to EU)
| + | *[[Myxomatosis]] |
− | *Myxomatosis | |
| *Fowl pox | | *Fowl pox |
| *Pigeon pox | | *Pigeon pox |
| *Canary pox | | *Canary pox |
− | *Ectromelia (mice) | + | *[[Ectromelia]] |
| *Camel pox | | *Camel pox |
| *Monkey pox | | *Monkey pox |
Line 49: |
Line 76: |
| | | |
| | | |
− | =Diagnosis=
| |
− |
| |
− |
| |
− | =Control=
| |
− | ==Introduction==
| |
− |
| |
− | ==Orthopoxviruses==
| |
| | | |
| ==Parapoxviruses== | | ==Parapoxviruses== |